MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation

Emily S Nia1, Beatriz E Adrada1, Gary J Whitman1

  • 1Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

The Breast Journal
|January 4, 2021
PubMed

Insights

Pseudoangiomatous stromal hyperplasia (PASH) on MRI imaging often appears as nonmass enhancement, but its appearance does not reliably correlate with PASH amount. This suggests PASH is typically an incidental finding during breast lesion biopsies.

Area of Science:

  • Radiology
  • Pathology
  • Oncology

Background:

  • Pseudoangiomatous stromal hyperplasia (PASH) is a rare, benign breast lesion.
  • PASH is frequently discovered incidentally during the analysis of other breast lesions via biopsy.

Purpose of the Study:

  • To characterize the magnetic resonance imaging (MRI) appearance of PASH.
  • To determine the correlation between MRI findings and the proportion of PASH in pathology specimens.

Main Methods:

  • Retrospective analysis of 69 patients with PASH diagnosed via MRI-guided biopsy (2008-2015).
  • Review of pre-biopsy MRI scans to document lesion characteristics.
  • Pathology specimens classified by PASH percentage (≤50% or ≥51%).

Main Results:

  • PASH lesions on MRI presented as foci (13%), masses (28%), or nonmass enhancement (59%).
  • Nonmass enhancements most commonly demonstrated persistent kinetic features (80%).
  • No significant correlation was found between MRI appearance (mass, focus, nonmass enhancement) and PASH percentage (P ≥ 0.05).

Conclusions:

  • PASH exhibits diverse appearances on MRI, frequently presenting as nonmass enhancement with persistent kinetics.
  • The majority of PASH specimens contained ≤50% PASH, supporting its role as an incidental finding.
  • No definitive MRI imaging characteristic reliably identifies PASH.